技术创新案例(技术经济学)（Case study of technological innovation (Technical Economics)）.doc

技术创新案例(技术经济学)（Case study of technological innovation (Technical Economics)） Collected by oneself Mistakes are unavoidable For reference only In case of error Please correct me! Thank you Practical technical and economic innovation case of enterprise North China Pharmaceutical Refco Group Ltd (Hua Yuan north pharmaceutical factory) Hereinafter referred to as medicine group or medicine) is a large state-owned enterprise built 15 It is an important base of antibiotic production in China Its penicillin output accounted for more than 1/2 of the country Factory construction for more than 40 years Especially, Chinas market economic system has been gradually established for more than ten years The enterprise suffers the shock of the domestic and foreign medicine market storm Overcoming the chronic illness in the state owned enterprise system Maintain the rapid growth of output value Benefit from adhering to the road of technological innovation and science and technology By the end of 1999 The company won 5 national invention awards National Science and technology progress award 18 Provincial and ministerial level awards for science and technology 70 In China, more than ten varieties, such as Pingyang, lincomycin and so on, were developed Chinas pharmaceutical market to fill the gap Only 85 period The company will put in more than 30 new products and new products And the implementation of various types of joint ventures, cooperation and technical transformation projects amounted to more than 20 1999 The companys new products, new varieties, new specifications, products worth 900 million yuan Since 2000, one or two innovative drugs or modern biotechnology drugs have been sold on the market each year At present, the company produces 5 large series of more than 430 varieties of products The Chinese medicine groups overall strategic objectives are: 2010 In the strength to maintain the domestic first Among the worlds top 30 pharmaceutical companies North China Pharmaceutical Gro